Any current/future new fundraising through debt or equity?

Cyient Semiconductor, a step-down subsidiary of Cyient Limited, is planning a new fundraising. The fundraise will be a combination of debt and equity. The purpose is to support growth and working capital needs of the semiconductor business. Initial equity dilution targeted is relatively small, not exceeding 10-12%. Engagement with bankers is ongoing, and final details will be shared once approved. This fundraising is separate from Cyient Limited’s buyback program and is focused solely on the semiconductor business. The Board has approved the buyback of shares by Cyient Limited but the promoter

Any current/future capex/capital investment/strategic investment?

Cyient is making strategic investments in its semiconductor business, which have impacted margins but are intentional for long-term growth. The company plans to raise capital (up to ~10-12% dilution) specifically for Cyient Semiconductor to reach breakeven and fund growth. Cyient has paused a large-scale strategic acquisition (Project Astro) due to rapid AI evolution and geopolitical uncertainties; decision to proceed is pending. Continued investments in AI and digital platforms (e.g., Agentic platform, Engineering Intelligence platform) to transform service lines and drive future growth. Sust

Future growth expectations in sales/revenue/volumes?

Cyient expects mid- to high single-digit organic revenue growth year-over-year in FY27. Growth will be driven by strength in two to three key markets. Despite current market dynamics, confidence remains that these markets will produce enough strength to achieve growth targets. Some deal delays impacted Q4 revenue but are expected to normalize, with specific pushbacks in connectivity projects already underway. Large deals pipeline is increasing across 5 out of 7 market segments, notably led by connectivity and healthcare, with expansion into other markets anticipated. Strategic initiatives, inc

Future growth expectations in earnings/operating earnings/profits/EPS?

Cyient aspires to achieve mid- to high single-digit organic revenue growth year-over-year in FY27. The target is to reach a 15% EBIT margin by Q4 of FY27, which translates to approximately 17-17.5% EBITDA margin. Margin expansion levers include price hikes, cost savings through automation and AI, administrative cost reductions, and forex tailwinds. AI is seen as an opportunity to enhance cost efficiency and drive structured growth across service lines. Despite near-term volatility from geopolitical factors, Cyient remains confident in achieving its growth and margin targets. The semiconductor

Current/ Expected Orderbook/ Pending Orders?

In H2 FY26, order intake grew by 5.5% year-over-year compared to H2 FY25. Q4 order intake saw a strong 23% growth over the previous year. Large deals are increasing across 5 out of 7 market segments, with leadership from connectivity and healthcare. Order book for Cyient DLM is at its highest historical level with a book-to-bill ratio of 1.5x. Typically, about 75% of order intake/order book converts to revenue within 9 months. Some specific deals delayed start from Q4 FY26 to Q1 FY27 but are limited and will not impact the full-year outlook. Pipeline continues to grow as a percentage of new bu

IN US

Sale is live|00:00:00left today

Cyient LtdQ1 FY26IT - Services

Cyient Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹888P/E: 20.3Market Cap: ₹9.7K CrSector: IT - Services

Management growth scorecard

Revenue

Category 4

Margin

Category 1

Fundraise

Yes

Order

Yes

Capex

Yes

4 of 5 growth signals are positive — a strong management growth story.

Full analysis

Revenue guidance

Category 4

→Cyient expects mid- to high single-digit organic revenue growth year-over-year in FY27.
→Growth will be driven by strength in two to three key markets.
→Despite current market dynamics, confidence remains that these markets will produce enough strength to achieve growth targets.
→Some deal delays impacted Q4 revenue but are expected to normalize, with specific pushbacks in connectivity projects already underway.
→Large deals pipeline is increasing across 5 out of 7 market segments, notably led by connectivity and healthcare, with expansion into other markets anticipated.
→Strategic initiatives, including AI and digital transformations, are expected to support future growth.
→Semiconductor business is projected to reach about $100 million in revenue, though margins will still be negative due to ongoing investments.

Margin guidance

Category 1

→Cyient aspires to achieve mid- to high single-digit organic revenue growth year-over-year in FY27.
→The target is to reach a 15% EBIT margin by Q4 of FY27, which translates to approximately 17-17.5% EBITDA margin.
→Margin expansion levers include price hikes, cost savings through automation and AI, administrative cost reductions, and forex tailwinds.
→AI is seen as an opportunity to enhance cost efficiency and drive structured growth across service lines.
→Despite near-term volatility from geopolitical factors, Cyient remains confident in achieving its growth and margin targets.
→The semiconductor business is expected to grow towards a $100 million revenue scale in FY27 but will remain margin negative due to ongoing investments.
→The company plans continued strategic investments and a cautious approach given evolving market dynamics and AI impact.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→Cyient Semiconductor, a step-down subsidiary of Cyient Limited, is planning a new fundraising.
→The fundraise will be a combination of debt and equity.
→The purpose is to support growth and working capital needs of the semiconductor business.
→Initial equity dilution targeted is relatively small, not exceeding 10-12%.
→Engagement with bankers is ongoing, and final details will be shared once approved.
→This fundraising is separate from Cyient Limited’s buyback program and is focused solely on the semiconductor business.
→The Board has approved the buyback of shares by Cyient Limited but the promoters will not participate, reflecting confidence in the company’s value.
→No immediate large-scale fundraise mentioned for Cyient Limited's core business.

Order book

Yes

→In H2 FY26, order intake grew by 5.5% year-over-year compared to H2 FY25.
→Q4 order intake saw a strong 23% growth over the previous year.
→Large deals are increasing across 5 out of 7 market segments, with leadership from connectivity and healthcare.
→Order book for Cyient DLM is at its highest historical level with a book-to-bill ratio of 1.5x.
→Typically, about 75% of order intake/order book converts to revenue within 9 months.
→Some specific deals delayed start from Q4 FY26 to Q1 FY27 but are limited and will not impact the full-year outlook.
→Pipeline continues to grow as a percentage of new business each quarter, indicating robust future funnel.

Capex plans

Yes

→Cyient is making strategic investments in its semiconductor business, which have impacted margins but are intentional for long-term growth.
→The company plans to raise capital (up to ~10-12% dilution) specifically for Cyient Semiconductor to reach breakeven and fund growth.
→Cyient has paused a large-scale strategic acquisition (Project Astro) due to rapid AI evolution and geopolitical uncertainties; decision to proceed is pending.
→Continued investments in AI and digital platforms (e.g., Agentic platform, Engineering Intelligence platform) to transform service lines and drive future growth.
→Sustained fiber build-out spend in North America and EMEA for the next 3 to 5 years, aligned with large customer network expansion plans.
→Significant focus on capex and capital discipline with buyback announced, which is among the largest in the tech sector reflecting strong cash flow confidence.

How does Cyient Ltd rank vs peers in IT - Services?

Pro feature

1Cyient Ltd

Rev 4Mar 1

See full IT - Services sector rankings

Want more stocks like Cyient Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio